Skip to main content
. 2016 Aug 2;7(35):56241–56252. doi: 10.18632/oncotarget.11025

Table 1. Top 10 drugs selected by PDX screening.

PhLO viability (%) Relative MTT value of ALL1 Relative MTT value of S17
Pentoxifylline 0 0.46 0.87
Rilmenidine hemifumarate 0 0.66 0.75
AC-93253 iodide 0 0.29 0.83
Idarubicin 0 0.26 0.82
Chicago sky blue 6B 0 0.91 0.55
Pyrvinium pamoate 0 0.34 0.38
Aurantimycin A 0 0.21 0.29
Verteporfin Stattic 0.01 9.9 1.08 0.19 0.3 0.69